"
Template:WUR
From 2012.igem.org
(Difference between revisions)
TSlijkhuis (Talk | contribs) |
MarkvanVeen (Talk | contribs) |
||
| (18 intermediate revisions not shown) | |||
| Line 40: | Line 40: | ||
<ul> | <ul> | ||
<li>[[Team:Wageningen_UR/Project|1. Introduction]]</li> | <li>[[Team:Wageningen_UR/Project|1. Introduction]]</li> | ||
| - | <li>[[Team:Wageningen_UR/Coil_system | + | <li>[[Team:Wageningen_UR/Coil_system|2. PnA System]]</li> |
<li class="hassubitems"> | <li class="hassubitems"> | ||
| - | <span>[[Team:Wageningen_UR/VLPs | + | <span>[[Team:Wageningen_UR/VLPs|3. Virus-Like Particles]]</span> |
<ul> | <ul> | ||
| - | <li>[[Team:Wageningen_UR/ModifyingtheCCMV | + | <li>[[Team:Wageningen_UR/ModifyingtheCCMV|CCMV]]</li> |
| - | <li>[[Team:Wageningen_UR/ModifyingtheHepatitisB | + | <li>[[Team:Wageningen_UR/ModifyingtheHepatitisB|HepB]]</li> |
| - | <li>[[Team:Wageningen_UR/ObtainingthePoleroVLP | + | <li>[[Team:Wageningen_UR/ObtainingthePoleroVLP|''Polerovirus'' Natural BioBrick]]</li> |
</ul> | </ul> | ||
</li> | </li> | ||
| Line 62: | Line 62: | ||
<li>[[Team:Wageningen_UR/miniSymposium#Online_video_symposium|1. Mini Symposium]]</li> | <li>[[Team:Wageningen_UR/miniSymposium#Online_video_symposium|1. Mini Symposium]]</li> | ||
<li>[[Team:Wageningen_UR/Visiting_Secondary_School#Visiting_Secondary_Schools|2. Visiting Secondary Schools]]</li> | <li>[[Team:Wageningen_UR/Visiting_Secondary_School#Visiting_Secondary_Schools|2. Visiting Secondary Schools]]</li> | ||
| - | <li>[[Team:Wageningen_UR/DiscoveryFestival#Discovery_festival|3. Discovery Festival]]</li> | + | <li class="hassubitems"> |
| + | [[Team:Wageningen_UR/DiscoveryFestival#Discovery_festival|3. Discovery Festival]] | ||
| + | <ul><li>[[Team:Team:Wageningen_UR/DiscoveryFestival_Communication|Communication Science]]</li></ul> | ||
| + | </li> | ||
<li>[[Team:Wageningen_UR/Stakeholders#Stakeholders|4. Stakeholders]]</li> | <li>[[Team:Wageningen_UR/Stakeholders#Stakeholders|4. Stakeholders]]</li> | ||
<li>[[Team:Wageningen_UR/CASconference#Synthetic_Biology_CAS-conference_Munich|5. Munich CAS Conference]]</li> | <li>[[Team:Wageningen_UR/CASconference#Synthetic_Biology_CAS-conference_Munich|5. Munich CAS Conference]]</li> | ||
| Line 75: | Line 78: | ||
<li>[[Team:Wageningen_UR/Regulations|3. Regulations]]</li> | <li>[[Team:Wageningen_UR/Regulations|3. Regulations]]</li> | ||
<li>[[Team:Wageningen_UR/Possible_Improvements|4. Safety suggestions]]</li> | <li>[[Team:Wageningen_UR/Possible_Improvements|4. Safety suggestions]]</li> | ||
| + | <li>[[Team:Wageningen_UR/Application_safety|5. Safety of applications]]</li> | ||
</ul> | </ul> | ||
| + | </li> | ||
| + | <li> | ||
| + | <span>[[Team:Wageningen_UR/Modeling|Modeling]]</span> | ||
| + | <ul> | ||
| + | <li><span>[[Team:Wageningen_UR/HumanBody|Human Body Model]]</span></li> | ||
| + | <li><span>[[Team:Wageningen_UR/InSilico|Tertiary folding prediction]]</span></li> | ||
| + | <li><span>[[Team:Wageningen_UR/FormationModel|VLP assembly model]]</span></li> | ||
| + | </ul> | ||
</li> | </li> | ||
<li><span>[[Team:Wageningen_UR/Attributions|Attributions]]</span></li> | <li><span>[[Team:Wageningen_UR/Attributions|Attributions]]</span></li> | ||
<li><span>[[Team:Wageningen_UR/Parts|Parts]]</span></li> | <li><span>[[Team:Wageningen_UR/Parts|Parts]]</span></li> | ||
| - | |||
<li> | <li> | ||
<span>[[Team:Wageningen_UR/Notebook|Notebook]]</span> | <span>[[Team:Wageningen_UR/Notebook|Notebook]]</span> | ||
| Line 109: | Line 120: | ||
<img src="https://static.igem.org/mediawiki/2012/5/51/Fbteam.png" alt="Team" width="170" height="190" /> | <img src="https://static.igem.org/mediawiki/2012/5/51/Fbteam.png" alt="Team" width="170" height="190" /> | ||
</a> | </a> | ||
| - | <a href="/Team:Wageningen_UR/ | + | <a href="/Team:Wageningen_UR/Project" title="Project Overview"> |
<img src="https://static.igem.org/mediawiki/2012/7/75/Fbprojectoverview.png" alt="Project Overview" width="170" height="190" /> | <img src="https://static.igem.org/mediawiki/2012/7/75/Fbprojectoverview.png" alt="Project Overview" width="170" height="190" /> | ||
</a> | </a> | ||
| Line 115: | Line 126: | ||
<img src="https://static.igem.org/mediawiki/2012/1/13/Fbconstructor.png" alt="The Constructor" width="170" height="190" /> | <img src="https://static.igem.org/mediawiki/2012/1/13/Fbconstructor.png" alt="The Constructor" width="170" height="190" /> | ||
</a> | </a> | ||
| - | <a href="/Team:Wageningen_UR/ | + | <a href="/Team:Wageningen_UR/Human_Practices" title="Human Practices"> |
<img src="https://static.igem.org/mediawiki/2012/a/a7/Fbhumanpractices.png" alt="Human Practices" width="170" height="190" /> | <img src="https://static.igem.org/mediawiki/2012/a/a7/Fbhumanpractices.png" alt="Human Practices" width="170" height="190" /> | ||
</a> | </a> | ||
| Line 140: | Line 151: | ||
<div class="fullfooter"> | <div class="fullfooter"> | ||
| - | <html><img src="https://static.igem.org/mediawiki/2012/1/11/Wur_sponsors.png" alt="We thank our sponsors: DSM, Middelhoven Fund | + | <html> |
| + | <h4>Our Sponsors:</h4> | ||
| + | <img src="https://static.igem.org/mediawiki/2012/1/11/Wur_sponsors.png" alt="We thank our sponsors: AFSG, Agilent Technologies, Baseclear, DSM, ERASynBio, Gilson, Middelhoven Fund, NBV, SBN, SurfRender, VLAG, Wageningen UR" /></html> | ||
</div> | </div> | ||
</div> | </div> | ||
Latest revision as of 18:03, 26 October 2012
